Welcome to EU-OPENSCREEN

For academic researchers and companies aiming to utilise chemical biology tools to advance basic research or early drug discovery projects, EU-OPENSCREEN is a not-for-profit European Research Infrastructure Consortium (ERIC) dedicated to supporting your research at every stage.

Our network includes 30 partner sites, featuring facilities for compound screening, medicinal chemistry, and chemoproteomics, and spans leading research institutions across eight European countries. By accessing our compound collections, you can leverage advanced technologies and expert guidance to develop tool compounds and high-quality leads. Our European Chemical Biology Database offers new insights into your targets or disease-relevant pathways.

Securing project funding can be challenging, but through the EU-OPENSCREEN network, we provide support for your grant proposals, risk-sharing models, or public-private collaborations. Our network has secured millions of Euros in research funding over the past decade.

Join the EU-OPENSCREEN community to explore our resources, collaborate with top experts, and make new discoveries together. Welcome to EU-OPENSCREEN, your collaborative research partner in chemical biology and early drug discovery. 

 

 
 
 
 

Our Services

Screening

We offer biologists the chance to screen their assays against our high-quality compound collections and identify promising hit compounds.
Read more

Data

Our bioactivity data covering 4M data points are collected in an open access database. This resource is extremely helpful for ML applications.
Read more

Medicinal chemistry

Our medicinal chemistry sites will optimise molecules towards probes and leads.
Read more

Project funding

While we don't provide direct funding for projects, we provide our expert input into grant proposals and business plans.
Read more

Compound sharing

We invite chemists to submit their compounds to our screening collection to discover novel bioactivities.
Read more

Training

Providing training is one of our core activities to support the effective use of our infrastructure and help develop future European researchers.
Read more

News and basic facts on EU-OPENSCREEN

Essential principles in a nutshell - explanation videos

Introduction video on profile and services
Services for biological applications
Benefit from adding your compound

News from our network

The EU-OPENSCREEN team is excited to highlight that this week's SLAS conference in San Diego, California, will see Phil Gribbon becoming the SLAS President for 2025. The SLAS is the largest…

Read more

EU-OPENSCREEN co-organises the next International Helmholtz Drug Discovery Conference 2025 (HDDC2025) at the MDC.C in Berlin. The focus of HDDC2025 is RNA as drug and drug target, Novel cardiovascular…

Read more

   

Basic Facts and Partner Sites

Learn more about our network and the distributed facilities around Europe

Read more

Access EU-OPENSCREEN

Get an overview of our screening and compound workflow and your opportunities to join!

Read more

Success Stories

More than 80 user projects have been successfully launched within our infrastructure!

Read more